Gujarat Terce Laboratories Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹20
- Today's High:
- ₹22.06
- Open Price:
- ₹22.06
- 52W Low:
- ₹14.55
- 52W High:
- ₹31.62
- Prev. Close:
- ₹21.02
- Volume:
- 14005
Company Statistics
- Market Cap.:
- ₹59.66 million
- Book Value:
- 14.974
- Revenue TTM:
- ₹355.87 million
- Operating Margin TTM:
- 3.23%
- Gross Profit TTM:
- ₹232.78 million
- Profit Margin:
- 2.95%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Gujarat Terce Laboratories Limited had its IPO on under the ticker symbol 524314.
The company operates in the Other sector and Other industry. Gujarat Terce Laboratories Limited has a staff strength of 329 employees.
Stock update
Shares of Gujarat Terce Laboratories Limited opened at ₹22.06 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹20 - ₹22.06, and closed at ₹21.99.
This is a +4.61% increase from the previous day's closing price.
A total volume of 14,005 shares were traded at the close of the day’s session.
In the last one week, shares of Gujarat Terce Laboratories Limited have increased by +29.2%.
Gujarat Terce Laboratories Limited's Key Ratios
Gujarat Terce Laboratories Limited has a market cap of ₹59.66 million, indicating a price to book ratio of 0.5664 and a price to sales ratio of 0.1907.
In the last 12-months Gujarat Terce Laboratories Limited’s revenue was ₹355.87 million with a gross profit of ₹232.78 million and an EBITDA of ₹14.00 million. The EBITDA ratio measures Gujarat Terce Laboratories Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Gujarat Terce Laboratories Limited’s operating margin was 3.23% while its return on assets stood at 0% with a return of equity of 0%.
In Q3, Gujarat Terce Laboratories Limited’s quarterly earnings growth was a positive 0% while revenue growth was a negative 28.2%.
Gujarat Terce Laboratories Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 6.0871
- PEG
Its diluted EPS in the last 12-months stands at ₹1.413 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Gujarat Terce Laboratories Limited’s profitability.
Gujarat Terce Laboratories Limited stock is trading at a EV to sales ratio of 0.2927 and a EV to EBITDA ratio of 181.5519. Its price to sales ratio in the trailing 12-months stood at 0.1907.
Gujarat Terce Laboratories Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹285.27 million
- Total Liabilities
- ₹166.08 million
- Operating Cash Flow
- ₹6.15 million
- Capital Expenditure
- ₹631000
- Dividend Payout Ratio
- 0%
Gujarat Terce Laboratories Limited ended 2024 with ₹285.27 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹285.27 million while shareholder equity stood at ₹68.63 million.
Gujarat Terce Laboratories Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹166.08 million in other current liabilities, -5576000.00 in common stock, ₹74.20 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹0 and cash and short-term investments were ₹20.30 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹14.61 million.
Gujarat Terce Laboratories Limited’s total current assets stands at ₹160.48 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹79.86 million compared to accounts payable of ₹0 and inventory worth ₹44.30 million.
In 2024, Gujarat Terce Laboratories Limited's operating cash flow was ₹6.15 million while its capital expenditure stood at ₹631000.
Comparatively, Gujarat Terce Laboratories Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹21.99
- 52-Week High
- ₹31.62
- 52-Week Low
- ₹14.55
- Analyst Target Price
- ₹
Gujarat Terce Laboratories Limited stock is currently trading at ₹21.99 per share. It touched a 52-week high of ₹31.62 and a 52-week low of ₹31.62. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹22 and 200-day moving average was ₹19.32 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4404.1% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Gujarat Terce Laboratories Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Gujarat Terce Laboratories Limited manufactures and markets medical and pharmaceutical preparations in India. The company offers branded and generic formulations covering various therapeutic, such as antibiotics, respiratory, nutraceuticals, gastrointestinal, anti-fungal, and others. It provides its products in various forms, such as tablets, capsules, oral liquids, injections, and ointments. The company also exports its products. Gujarat Terce Laboratories Limited was founded in 1985 and is based in Ahmedabad, India.